Literature DB >> 34532814

Long non-cording RNA XIST promoted cell proliferation and suppressed apoptosis by miR-423-5p/HMGA2 axis in diabetic nephropathy.

Hui Chen1,2, Yuan Guo3, Xingbo Cheng4.   

Abstract

This research studied the effect of long non-coding RNA X-inactive-specific transcript (XIST) on DN. The effect of high glucose (HG) on the expression of XIST and miR-423-5p was detected by quantitative real-time PCR (qRT-PCR) in human kidney (HK) cells (human glomerular mesangial cells (HMCs) and human kidney-2 (HK-2) cells). The effect of XIST depletion and miR-423-5p inhibition or overexpression on high mobility group protein A2 (HMGA2) protein level was examined by western blot in HG-induced HK cells. The impacts of XIST depletion on viability and apoptosis were assessed by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) and flow cytometry assays in HG-induced HK cells. We found the expression of XIST and HMGA2 protein was significantly upregulated in DN tissues and cells. Moreover, HG treatment induced the upregulation of XIST and HMGA2 protein level in HK cells. Besides, both XIST depletion and HMGA2 depletion decreased cell proliferation but increased apoptosis in HG-treated HK cells. Furthermore, HMGA2 upregulation or miR-423-5p inhibition partly eliminated the effects of XIST depletion on cell proliferation, apoptosis of HG-treated HK cells. Interestingly, HMGA2 upregulation partly reversed miR-423-5p overexpression-mediated suppression on viability and promotion on apoptosis in HG-treated HK cells. Mechanistically, XIST sponged miR-423-5p to regulate HMGA2 expression in DN cells. Taken together, XIST depletion suppressed proliferation and promoted apoptosis via miR-423-5p/HMGA2 axis in HG-treated HK cells, which may provide a potential therapeutic target for DN.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Diabetic nephropathy; HMGA2; High glucose; XIST; miR-423-5p

Mesh:

Substances:

Year:  2021        PMID: 34532814     DOI: 10.1007/s11010-021-04250-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  44 in total

Review 1.  Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus.

Authors:  J Schwieger; L G Fine
Journal:  Semin Nephrol       Date:  1990-05       Impact factor: 5.299

2.  The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.

Authors:  M Al-Douahji; J Brugarolas; P A Brown; C O Stehman-Breen; C E Alpers; S J Shankland
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

Review 3.  Diabetic nephropathy and inflammation.

Authors:  Montserrat B Duran-Salgado; Alberto F Rubio-Guerra
Journal:  World J Diabetes       Date:  2014-06-15

4.  Reversal of lesions of diabetic nephropathy after pancreas transplantation.

Authors:  P Fioretto; M W Steffes; D E Sutherland; F C Goetz; M Mauer
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245

Review 5.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 6.  Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Authors:  Fuad N Ziyadeh; Gunter Wolf
Journal:  Curr Diabetes Rev       Date:  2008-02

7.  Kidney disease and increased mortality risk in type 2 diabetes.

Authors:  Maryam Afkarian; Michael C Sachs; Bryan Kestenbaum; Irl B Hirsch; Katherine R Tuttle; Jonathan Himmelfarb; Ian H de Boer
Journal:  J Am Soc Nephrol       Date:  2013-01-29       Impact factor: 10.121

Review 8.  microRNAs in Diabetic Kidney Disease.

Authors:  Arthur C K Chung
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 9.  Hydrogen Sulfide in Renal Physiology and Disease.

Authors:  Denis Feliers; Hak Joo Lee; Balakuntalam S Kasinath
Journal:  Antioxid Redox Signal       Date:  2016-05-31       Impact factor: 8.401

Review 10.  Effect of redox modulating NRF2 activators on chronic kidney disease.

Authors:  Bo-hyun Choi; Kyung-Shin Kang; Mi-Kyoung Kwak
Journal:  Molecules       Date:  2014-08-20       Impact factor: 4.411

View more
  1 in total

Review 1.  Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?

Authors:  Weronika Kraczkowska; Lucyna Stachowiak; Andrzej Pławski; Paweł Piotr Jagodziński
Journal:  J Appl Genet       Date:  2022-01-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.